cancers-logo

Journal Browser

Journal Browser

Metabolic Syndrome in Cancer

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".

Deadline for manuscript submissions: closed (31 October 2024) | Viewed by 1745

Special Issue Editors


E-Mail Website
Guest Editor
Department of Interdisciplinary Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, 1170124 Bari, Italy
Interests: tumorigenesis; hepatocellular carcinoma; hepatology; gastroenterology

E-Mail Website
Guest Editor
Department of Interdisciplinary Medicine, University of Bari “Aldo Moro”, Italy Piazza Giulio Cesare, 1170124 Bari, Italy
Interests: metabolic sydrome; cancer; diet and cancer

Special Issue Information

Dear Colleagues,

The complexity of the epidemiological evidence around the relationship between obesity and cancer reflects the wide interplay among metabolic pathways involved in cancer development, progression, and pharmacological responsiveness. To date, a plethora of circulating factors and molecular alterations, whereby obesity can lead to carcinogenesis, have been detected. Despite this, the primarily relevant mechanisms are not well understood. Since it is very clear that obesity is one modifiable risk factor for tumorigenesis, lifestyle interventions addressed at reducing adiposity, including dietary changes and physical activity, play a pivotal role in cancer prevention.

This research topic focuses on the metabolic pathways responsible for carcinogenesis, their epidemiology and prevention strategies, the modulation of therapeutic approaches, the role of dietary and lifestyle interventions, and predictions of prognosis, with the aim of assessing at-risk populations and proposing new prevention strategies.

Prof. Dr. Antonio Moschetta
Dr. Lucilla Crudele
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • metabolic diseases
  • cancer
  • obesity
  • microbiome
  • nutrition
  • carcinogenesis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 276 KiB  
Article
A Qualitative Study of the Knowledge of Metabolic Syndrome, Attitudes about Lifestyle Modifications, and Preferences for Lifestyle Interventions among Patients with Cancer and Metabolic Syndrome
by Isabel Martinez Leal, Ashwathy B. Pillai, Jessica T. Foreman, Kimberly W. Siu, Natalia I. Heredia, Carmen P. Escalante, Ellen F. Manzullo, Aimee J. Christie, Tamara E. Lacourt, Zayd Adnan Razouki and Jessica P. Hwang
Cancers 2024, 16(18), 3147; https://doi.org/10.3390/cancers16183147 - 13 Sep 2024
Cited by 2 | Viewed by 1373
Abstract
Metabolic syndrome is a group of disorders—hypertension, dyslipidemia, obesity, and insulin resistance—that together increase the risk of coronary heart disease, stroke, and diabetes. Although ~60% of cancer patients have metabolic syndrome, which increases their risk of mortality, oncology providers lack clear guidance about [...] Read more.
Metabolic syndrome is a group of disorders—hypertension, dyslipidemia, obesity, and insulin resistance—that together increase the risk of coronary heart disease, stroke, and diabetes. Although ~60% of cancer patients have metabolic syndrome, which increases their risk of mortality, oncology providers lack clear guidance about its management. The development of metabolic syndrome lifestyle interventions requires a better understanding of these patients’ knowledge, attitudes, and intervention preferences in order to inform management. During 2022–2023, 19 adult cancer patients with metabolic syndrome engaged in semistructured interviews focused on metabolic syndrome and lifestyle interventions. Interviews were analyzed using hybrid thematic analysis involving deductive and inductive coding. The findings indicated that patients lack knowledge about metabolic syndrome, were motivated to prioritize lifestyle modifications, and expressed strong interest in personalized care plans focused on healthy lifestyle rather than simply on weight loss. As part of their tailored intervention plans, participants desired clear communication with, and coordination of care among, their medical team and shared decision-making with providers about treatment decisions. The findings indicate that patients with metabolic syndrome want collaborative, patient-centered care, tailored interventions, and practical implementation strategies. This research will be used to inform the development of future lifestyle interventions for patients diagnosed with metabolic syndrome based on their identified needs and preferences. Full article
(This article belongs to the Special Issue Metabolic Syndrome in Cancer)
Back to TopTop